AMBLER, Pa., Aug. 9, 2011 /PRNewswire/ — Allergy
Technologies LLC, manufacturer of
ActiveGuard™ mattress liners, is sponsoring
a new bed bug research program at The Ohio State University through
an initial $100,000+ grant provided by the Company.
This new endeavor will examine the importance and effects of
specific products, protocols and strategies relating to innovative
bed bug treatment applications. The dramatic rise in bed bug
infestations throughout the country in the last ten years has
created a need for more research to improve and expand pest
management practices. Based on mutual agreement between The Ohio
State University and Allergy Technologies, this grant provides a
2nd year renewal opportunity for an additional $100,000+ in
funding.
According to Susan Jones, Ph.D., entomologist at The Ohio State
University, the grant provided by Allergy Technologies will allow
Jones and her urban entomology team to pursue sorely needed bed
bug-related research leading to implementation of new and improved
strategies for controlling bed bugs.
“This grant will enable us to embark upon important and in-depth
research on product efficacy, treatment protocols, and application
methods as we work to control bed bugs,” said Dr. Jones. “With the
current emergence of bed bug infestations, Allergy Technologies’
sponsorship will allow us to pursue fundamental lab and applied
field research. This programmatic research is geared toward
investigating novel strategies in bed bug treatment leading to
improved and effective solutions.”
“We are proud to be able to support this university research.
This grant evidences Allergy Technologies’ continued
commitment to developing bona fide research-based treatments
aimed directly toward the bed bug scourge that is blanketing our
country,” stated Gus Carey, Managing Director of Allergy
Technologies.
ActiveGuard by Allergy Technologies LLC, is a th
‘/>”/>